Multiplex Assays Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Multiplex Assays Market Insights & Trends and it is Segmented by Type (Cell-Based Multiplex Assays, Protein Multiplex Assays, and Nucleic Acid Multiplex Assays), Technology (Multiplex Real-Time PCR, Flow Cytometry, and Other Technologies), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East, and Africa, and South America). The market provides the value (in USD million) for the above segments.

Multiplex Assays Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Multiplex Assays Industry Overview

The multiplex assay market is moderately competitive in nature. The companies are adopting various key strategies such as collaborations, partnerships, agreements, acquisition and new product launches to withhold their market position. Some of the key players in the market are Thermo Fisher Scientific, Inc., Abcam plc, Merck KGaA, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Quansys Biosciences Inc., and Promega Corporation among others.

Multiplex Assays Market Leaders

  1. Bio-Rad Laboratories, Inc.

  2. Merck KGaA

  3. Quansys Biosciences Inc.

  4. Thermo Fisher Scientific

  5. Abcam plc.

  6. *Disclaimer: Major Players sorted in no particular order
Multiplex Assays Market Concentration